Arash Salemi

New York Presbyterian Hospital, New York City, NY, USA

Are you Arash Salemi?

Claim your profile

Publications (10)19.25 Total impact

  • Article: Surgical Management of Multiple Coronary Artery Aneurysms.
    Dimitrios V Avgerinos, Arash Salemi
    [show abstract] [hide abstract]
    ABSTRACT: We describe the surgical management of three distinct coronary artery aneurysms in conjunction with coronary artery bypass grafting.
    Journal of Cardiac Surgery 04/2013; · 0.87 Impact Factor
  • Article: An assay to monitor bivalirudin levels on cardiopulmonary bypass.
    [show abstract] [hide abstract]
    ABSTRACT: Anticoagulation therapy for cardiopulmonary bypass in patients with recently diagnosed heparin-induced thrombocytopenia can be particularly challenging. Although heparin is the standard of care, in these situations anticoagulation is achieved with alternative agents such as direct thrombin inhibitors. Therapeutic concentrations are difficult to assess with direct thrombin inhibitors, and their use is riddled with bleeding and thrombotic complications. We report the successful use of a specific chromogenic antifactor IIa assay in a patient with heparin-induced thrombocytopenia who received anticoagulation therapy with bivalirudin during cardiopulmonary bypass for coronary artery bypass graft surgery.
    The Annals of thoracic surgery 07/2011; 92(1):332-4. · 3.74 Impact Factor
  • Article: Unplanned staged hybrid management of postmyocardial infarction ventricular septal defect.
    [show abstract] [hide abstract]
    ABSTRACT: Ventricular septal defect (VSD) is an uncommon but potentially deadly complication of transmural myocardial infarction (MI). Emergency surgical treatment has traditionally offered the best chance for survival. However, operative intervention is associated with high mortality and can be complicated by a recurrent VSD due to tissue friability around the infarcted area. Percutaneous catheter-based closure techniques can be used to treat these critically ill patients, offering a less invasive and less morbid technique. This case demonstrates the successful application of an unplanned, staged hybrid approach utilizing initial percutaneous and subsequent surgical repair after recovery of tissue integrity.
    Cardiology 03/2011; 118(1):38-41. · 1.71 Impact Factor
  • Article: An unusual case of cardiac tamponade: ruptured subaortic diverticulum.
    [show abstract] [hide abstract]
    ABSTRACT: Cardiac diverticula are rare congenital anomalies found as outpouchings from various chambers of the heart. We present a case of a diverticulum arising from the membranous septum with free rupture into the pericardial space and tamponade.
    Journal of Cardiac Surgery 03/2010; 25(3):349-50. · 0.87 Impact Factor
  • Article: A hybrid approach in the treatment of post-myocardial infarction ventricular septal defect.
    [show abstract] [hide abstract]
    ABSTRACT: Development of ventricular septal defect (VSD) is a rare but serious complication of transmural myocardial infarction (MI). The incidence of post-MI VSDs is reduced significantly with thrombolytic therapy, yet mortality remains high. Surgical repair is difficult and can be complicated by a recurrent VSD in some cases. Percutaneous catheter-based closure techniques can be used to treat these patients. This case report demonstrates the successful application of a hybrid approach utilizing initial surgical and subsequent percutaneous techniques for the recurrence in the treatment of a post-MI VSD.
    Cardiology 01/2010; 116(3):183-5. · 1.71 Impact Factor
  • Article: Intravenous leiomyomatosis with intracardiac extension: a single-institution experience.
    [show abstract] [hide abstract]
    ABSTRACT: The aim of this study was to outline the surgical management and outcomes for patients diagnosed with intravenous leiomyomatosis with intracardiac extension at a single institution. This was a retrospective review of patients diagnosed with intravenous leiomyomatosis with intracardiac extension between 2002-2008. Four patients were identified. The surgical approach in 3 (75%) patients was a single-stage operation. Four (100%) patients presented with cardiac symptoms: 3 (75%) with syncope and 1 (25%) with an abnormal electrocardiogram. Mean age at presentation was 48 years (range, 42-58 years). Complete resection of tumor was obtained in 1 (25%) patient and 3 (75%) patients experienced incomplete resection. Mean follow-up, including surveillance imaging, was 25.5 months (range, 8-57 months) and all 4 patients (100%) are currently free of recurrence. Surgical excision remains an effective therapy for treating patients with benign metastasizing leiomyomatosis. Incomplete surgical resection may result in favorable response.
    American journal of obstetrics and gynecology 10/2009; 201(6):574.e1-5. · 3.28 Impact Factor
  • Article: Ascaris lumbricoides infection causing respiratory distress after coronary artery bypass grafting.
    Stacy K Ugras, David J Finley, Arash Salemi
    [show abstract] [hide abstract]
    ABSTRACT: Ascaris lumbricoides infects an estimated 1.2 billion people worldwide, but is usually asymptomatic. Herein we report a case of acute respiratory distress caused by upper airway obstruction due to an adult A. lumbricoides nematodes after cardiac surgery. Case report and review of pertinent literature. A 70-year old female, until recently a resident of the rural Philippines, underwent coronary bypass grafting in New York City. Nine hours after surgery (one hour after endotracheal extubation), cough and arterial oxygen desaturation prompted airway suctioning, which retrieved an adult nematode from the posterior oroharynx. symptomes abated immediately, after which the patient receive a curative course of mebendazole. Although infection with A. lumbricoides is rare in the United States, it may become manifest with severe consequences in the postoperative period.
    Surgical Infections 10/2009; 11(2):177-8. · 1.80 Impact Factor
  • Article: Low-dose spironolactone: effects on artery-to-artery vein grafts and percutaneous coronary intervention sites.
    [show abstract] [hide abstract]
    ABSTRACT: The efficacy of vein grafts used in coronary and peripheral artery bypass is limited by excessive hyperplasia and fibrosis that occur early after engraftment. In the present study, we sought to determine whether low-dose spironolactone alleviates maladaptive vein graft arterialization and alters intimal reaction to coronary artery stenting. Yorkshire pigs were randomized to treatment with oral spironolactone 25 mg daily or placebo. All animals underwent right carotid artery interposition grafting using a segment of external jugular vein and, 5 days later, underwent angiography of carotid and coronary arteries. At that time, a bare metal stent was placed in the left anterior descending artery and balloon angioplasty was performed on the circumflex coronary artery. Repeat carotid and coronary angiograms were performed before euthanasia and graft excision at 30 days. Angiography revealed that venous grafts of spironolactone-treated animals had lumen diameters twice the size of controls at 5 days, a finding that persisted at 30 days. However, neointima and total vessel wall areas also were 2- to 3-fold greater in spironolactone-treated animals, and there were no differences in vessel wall layer thicknesses or collagen and elastin densities. In the coronary circulation, there were no differences between treatment groups in any vessel wall parameters in either stented or unstented vessels. Taken together, these observations suggest that low-dose spironolactone may exert a novel protective effect on remodeling in venous arterial grafts that does not depend on the reduction of hyperplastic changes but may involve dilatation of the vessel wall.
    American journal of therapeutics 04/2009; 16(3):204-14.
  • Article: A hypo-echoic, intramyocardial space: echocardiographic characteristics of an intramyocardial dissecting hematoma.
    Anesthesia and analgesia 01/2008; 105(6):1564-6. · 3.08 Impact Factor
  • Article: Percutaneous valve interventions.
    Arash Salemi
    [show abstract] [hide abstract]
    ABSTRACT: Open heart surgery has long been considered the gold standard for treatment of patients with valvular heart disease. Although results are excellent, this technique requires the use of cardiopulmonary bypass and is associated with protracted recovery and attendant risks of open surgery. The field of percutaneous valve interventions has emerged as a closed-chest alternative for all patients, but particularly those who otherwise would be considered too high risk for open surgery. Several devices are currently being evaluated in the clinical realm for each heart valve, particularly for the aortic and mitral positions. Early results are promising, but longer follow-up is necessary to determine durability of the procedures. Although only in its infancy, percutaneous valve therapies offer heart valve interventions without the use of cardiopulmonary bypass. This creates many new possibilities for patients, especially those who are deemed either high risk or inoperable by the usual surgical standards. Newer device iterations and longer term follow-up will be necessary as the field moves forward.
    Current Opinion in Anaesthesiology 03/2007; 20(1):70-4. · 2.21 Impact Factor

Institutions

  • 2010–2013
    • New York Presbyterian Hospital
      • Department of Cardiothoracic Surgery
      New York City, NY, USA
  • 2010–2011
    • Weill Cornell Medical College
      • Department of Cardiothoracic Surgery
      New York City, NY, USA
  • 2007
    • Cornell University
      New York City, NY, USA